Assessment of Tumor markers, C-reactive Protein, Cortisol and Total Plasma Peroxides Levels in Uterine Leiomyoma Patients by Akiibinu, Moses et al.
European Scientific Journal March 2017 edition vol.13, No.9 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
333 
Assessment of Tumor markers, C-reactive Protein, 
Cortisol and Total Plasma Peroxides Levels in Uterine 
Leiomyoma Patients 
 
 
 
Moses Akiibinu (PhD), 
Department of Biochemistry and Chemistry, Caleb University Lagos, 
Nigeria. 
Adebayo Amballi (MBBS, MSc), 
Department of Chemical Pathology and Immunology, Olabisi Onabanjo 
University, Sagamu, Ogun state, Nigeria. 
Olusoji Jagun (MBBS, FWACP), 
Department of Obstetrics and Gynaecology, Olabisi Onabanjo University, 
Sagamu, Ogun state, Nigeria. 
Ajibola Adisa (MSc), 
Clinical Chemistry Department, Midland Regional Hospital, Mullingar, 
Republic of Ireland. 
Susan Akiibinu (RNRM, BSc), 
Clinical Nursing Department, University College Hospital, Ibadan, Nigeria. 
Adeolu Amusan (MSc), 
Department of Chemical Pathology and Immunology, Olabisi Onabanjo 
University, Sagamu, Ogun state, Nigeria. 
Ibukun Jimo (MSc), 
Department of Biochemistry and Chemistry, Caleb University Lagos, 
Nigeria. 
Ayodele Olalekan (MSc), 
Chemical Pathology Department, University College Hospital, Ibadan, 
Nigeria. 
 
doi: 10.19044/esj.2017.v13n9p333        URL:http://dx.doi.org/10.19044/esj.2017.v13n9p333 
 
Abstract 
 Objective: The pathophysiology of uterine leiomyoma is yet to be 
fully understood. This study determined the status of cortisol, C-reactive 
protein, total plasma peroxide and selected tumor markers in uterine 
leiomyoma patients. 
Materials and Methods: Forty-eight individuals (aged 25-45 years) with 
uterine leiomyoma (nodules=1-4; size=5-120mm) were recruited for this 
study. Forty apparently age-matched normal individuals without uterine 
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leiomyoma served as controls. The patients and controls were selected after 
confirmation of the status of uterine leiomyoma by ultrasound imaging 
technique. The plasma levels of total plasma peroxides(TPP), cortisol, 
carcino-embryonic antigen(CEA), alpha fetoprotein (AFP), carbohydrate 
antigen 125(CA125) and C-reactive protein(CRP) were determined in them 
using spectrophotometry, enzyme linked immunosorbent assay and single 
radial immunodiffusion (Maccini) methods respectively. Results: The result 
shows significantly higher levels of TPP (p<0.001), CRP (p<0.001) and 
CA125 (p<0.002) in uterine leiomyoma patients when compared with the 
controls. There were no significant (p>0.05) changes in the plasma levels of 
cortisol, CEA and AFP in the leiomyoma patients when compared with the 
controls. Significant (r=0.521, p=0.03) correlation existed between the 
number of myoma nodules and the levels of CRP in the leiomyoma patients. 
The size of the nodules correlated significantly (r=0.47, p=0.04) with the 
plasma levels of TPP. Conclusion: Elevated levels of CRP and TPP could 
indicate oxidative stress and inflammatory response in uterine leiomyoma 
patients. The induced inflammation and oxidative stress may increase with 
increase in number and size of the myoma nodules respectively. Higher level 
of CA125 could be a feature of uterine leiomyoma. 
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Introduction 
Leiomyoma is a benign tumor originating as overgrowth of smooth 
muscle and connective tissue of the uterus, with ovarian steroid-dependent 
growth potential. It develops within the wall of the uterus of about 20% of 
women of reproductive ages when estrogen secretion is maximal (San Marco 
et al, 1991; Wallach and Vlahos, 2004; Jabbour et al, 2009). They bind 20% 
more estradiol per milligram of cytoplasmic protein than normal adjacent 
myometrium (Farber et al, 1972). The striking presence of erythropoietin 
receptor within myoma tissues contributes to the myoma size (Pollio et al, 
2005). Maruo et al (2003) and Maruo et al (2004) reported that progesterone 
and 17-beta-estradiol stimulate leiomyoma cell growth and survival through 
up-regulating epidermal growth factor. Uterine leiomyoma that grow as a 
single (solitary) nodule or clusters (multiple); may present as submucosal, 
intramuscular, subserosal or pedunculated forms and may range in size from 
1 mm to more than 20 cm (8 inches) in diameter (Stewart and Nowak, 1998). 
The tumor has a clonal karyotype with a complex structural rearrangement 
involving chromosomes 3, 12, 14, 17, and 22 with malignant potential in 
0.2% of cases (Gibas et al, 1988 and Parker et al, 1994). It is also 
characterized by abnormal nucleotide metabolism, increased 
deoxyribonucleic acid methylation (Yamagata et al, 2009) and extensive 
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coagulation necrosis (Katsumori et al, 2002). Certain genes in the fetal life 
are reactivated in certain tumors as surface proteins of cells in the adults as a 
result of abnormal or malignant transformation (Carl and Edward, 2001; 
Gadducci, 2004).  
In a normal uterus, there is expression of superoxide dismutase that 
regulates the constantly generated reactive oxygen species, which serve as a 
local protector of the uterus against infectious agents (Vural et al, 2012). But 
in a leiomyoma tissue, activation of infiltrating macrophages generate more 
free radicals, secrete interleukin-6 and several growth hormones including 
epidermal growth factor, transforming growth factor-α, transforming growth 
factor- β, heparin-binding epidermal growth factor, acidic fibroblast growth 
factor, basic fibroblast growth factor, vascular endothelial growth factor, 
insulin-like growth factor, platelet-derived growth factor, activin and 
myostatin in myometrium and in leiomyomas (Ciarmela et al, 2011). While 
the growth factors enhance the growth of the fibrous tissue of leiomyoma, 
the secreted interleukin-6 induces the hepatocytes to produce C-reactive 
protein (Jabbour et al, 2009). The excess free radical generation may further 
attack the DNA and increase the mutation rates, genome instability and loss 
of apoptosis in the tumor cells (Szabo and Ohshima, 1997). Several reports 
show that higher level of H2O2 is generated from cells that have 
mitochondrial DNA mutation during tumor development and progression 
(Bianchi et al, 2001; Mandavilli et al, 2002). The free-radical load and level 
of unbound iron in the leiomyoma tissue is indicative of the intensification of 
proliferative activity of the cells of uterine myoma, and one of the risk 
factors of neoplastic growth (Paĭlodze and Sanikidze, 2005). To investigate 
the cellular metabolic changes associated with pathologic proliferation of 
uterine leiomyoma tissues, the present study paid attention to the 
determination of total plasma peroxide (TPP), cortisol, C-reactive protein 
(CRP), carbohydrate antigen 125 (CA125), α-fetoprotein (AFP) and 
carcinoembryonic antigen (CEA) in uterine leiomyoma patients.  
 
Materials and Methods: 
Materials: 
Forty-eight individuals (aged 25-45 years) with uterine leiomyoma 
(nodules=1-4; size=5-120mm) were recruited for this study. Forty apparently 
age-matched normal individuals without uterine leiomyoma served as 
controls. The patients and controls were selected by cross sectional study 
from Oyo, Ogun and Lagos states of Nigeria. The presence or absence of 
uterine leiomyoma was confirmed by ultrasound imaging technique. The 
participants were free from metabolic or systemic disorders such as diabetes 
mellitus, hypertension, liver and renal diseases that could interfere with the 
findings in this study. None of them was a smoker or on systemic 
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medications that could affect oxidative stress, inflammation or protein 
synthesis. This study was approved by the Institutional Review Board, and 
informed consent obtained from all participants before the commencement of 
the study. 5ml of venous blood sample was taken from the anticubital vein of 
each participant into lithium heparin bottle and centrifuged for five minutes 
at 3,000 revolutions per minute, after which the plasma was separated and 
stored at -200C until analyzed. 
 
Methods: 
Determination of total plasma peroxide (TPP):  
Determination of total plasma peroxide levels made use of the 
reaction of ferrous-butylated hydroxytoluene-xylenol orange complex (F0X-
2 reagent) with plasma hydrogen peroxide, which yields a color complex that 
was measured spectrophotometrically at 560mm. H2O2 was used as standard. 
1.8ml of F0X-2 reagent was mixed with 200µ1 of plasma. This was 
incubated at room temperature for 30 minutes. 100µM H2O2/ L was used as 
standard. The mixture was centrifuged and the supernatant separated for 
reading at 560nm (Harma et al, 2003). 
 
Determination of plasma Cortisol, CA125, CEA and AFP: 
Five (5) ml of fasting blood sample was collected from each 
participant into lithium heparin bottle, centrifuged and the plasma stored at -
200C until ready for analysis. Cortisol, CA125, CEA and AFP were 
determined by using commercially prepared enzyme linked immunosorbent 
assay (ELISA) reagents (cat. numbers 24, 94K032, 1110010 and 1107029 
respectively) by InterMedical S.R.I. Villanicca (NA) Italy.  
Briefly, an aliquot of the plasma (at room temperature) was incubated 
with enzyme conjugate (corresponding monoclonal antiserum-antibody 
conjugated with horseradish peroxidase) in the microtiter wells coated with 
corresponding monoclonal antibody, directed towards a unique antigenic site 
of either cortisol, CA125, CEA or AFP. After incubation, the unbound 
conjugate was washed off, the wells drained and the substrate solution added 
for color development. Sulphoric acid was later added to stop the reaction. 
The intensity of the color corresponding to the concentration of the analyte 
was read at 450nm with TECO microplate reader, USA). 
 
Determination of plasma C-reactive protein (CRP): 
CRP was quantified by single radial immunodiffusion method as 
described by Salimonu et al (1978). A volume of an optimally diluted anti-
CRP antiserum was mixed with noble agar and poured on glass plate. Wells 
of equal diameters were cut in the antibody-agar mixture. The wells were 
European Scientific Journal March 2017 edition vol.13, No.9 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
337 
filled with test or standard sera. After incubation, the diameters of precipitin 
rings were measured using a Hyland viewer with a micrometer eyepiece. 
 
Statistical analysis: 
Data were expressed as Mean ± SD. Student’s (t) test was used for 
comparison of leiomyoma patients and controls. Pearsonian correlation 
coefficient (r) was calculated. Changes were considered significant when p-
values were less than 0.05. 
 
Results: 
Physical characteristics of uterine leiomyoma patients are similar to 
the controls (Table 1). In Table 2, the result shows significantly higher levels 
of TPP (p<0.001), CRP (p<0.001) and CA125 (p<0.002) in uterine 
leiomyoma patients when compared with the controls. But there were no 
significant (p=0.92, p=0.13 and p=0.35) changes in the plasma levels of 
cortisol, CEA and AFP respectively in the leiomyoma patients when 
compared with the controls. There was a significant (r=0.521, p=0.03) 
correlation between the number of myoma nodule and the levels of CRP in 
the leiomyoma patients as shown in Table 3. The size of the myoma nodules 
in the patients correlated significant (r=0.47, p=0.04) with the plasma levels 
of TPP as shown in Table 4.  
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Discussion: 
The etiology of uterine leiomyoma is poorly understood, but 
available information revealed that it is a slow growing non-cancerous 
macrophage infiltrated tumor, characterized by abnormal nucleotide 
metabolism, increased DNA methylation (Yamagata et al, 2009), loss of 
cyclin G1 expression, extensive coagulation necrosis (Kwon et al, 2008), 
hypercellularity, nuclear atypia, intravascular growth (Prayson and Hart 
1995) and chromosomal aberration (Stern et al, 1992). Sadlonova et al. 
(2008) reported metabolic dysfunctions such as abnormal membrane protein 
expression in leiomyoma patients. One of the main findings of the present 
study is that plasma level of CA125 increased significantly in leiomyoma 
patients. This study seems to corroborate the report of Tsao et al (2007) that 
demonstrated elevated levels of CA19.9 and CA125 in leiomyoma tissues. 
(Ghaemmaghami et al, 2007) also reported higher levels of CA125 in 
patients with other gynecologic diseases without malignant conditions. The 
possible changes already reported in the metabolic activities of uterine 
leiomyoma tissue could therefore account for the increased level of CA125 
in our uterine leiomyoma patients. This study did not demonstrate significant 
change in the level of CEA. Meanwhile, higher level of plasma CEA had 
been consistently reported in certain gynecologic malignancies (DiSaia et al, 
1975). Since inflammatory cytokines (i.e. IL1 and IL6) that induce the 
synthesis of CRP have suppressive effects on the synthesis of albumin and 
AFP, it could be hypothesized in this study that insignificant change in the 
level of AFP observed in this study may be associated with  increased level 
of CRP observed in the leiomyoma patients. This study seems to agree with 
the report by Philippoussis et al (2004) that patients with endometriosis did 
not show significant change in the serum level of AFP.  
Cells of the endometrium generate reactive oxygen species as its 
local protectors against pathogens. But the free radicals are regulated by 
superoxide dismutase also released into the uterus (Vural et al, 2012). Since 
Bianchi et al. (2001) and Mandavilli et al. (2002) reported that higher level 
of hydrogen peroxide was generated from cells that have mitochondrial DNA 
mutation during tumor development and progression, the deregulated level of 
TPP observed in our leiomyoma patients could be due to enhanced free 
radical generation in the macrophage infiltrated myoma tissues. It could also 
be due to increased surface area of larger myoma that causes enhanced 
prostaglandin activity needed for myometrial contraction; to maintain 
homeostasis at menstruation, cellular injury, inflammations or 
vasoconstriction-induced hypoxia during menstruation (Stewart and Nowak, 
1998). Our findings are consistent with previous studies reporting elevated 
oxidative stress in leiomyoma patients (Punnonen et al, 1993 and Ghiselli et 
al, 2000). Thalmann et al. (2000) and Kumar et al. (2008) also observed 
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increased free radical generation and metabolic dysfunctions in tumor cells 
when compared with normal cells. This higher free radical load has been 
associated with higher malondialdehyde in the uterine myoma patients 
(Chiou and Hu, 1999). To the knowledge of the authors, this is the first study 
that shows significant positive correlation between the size of the myoma 
nodules and plasma levels of TPP. This excessive generation of hydrogen 
peroxides in relation to the size of the tumor may contribute to the 
progressive DNA damage and genomic instability that could facilitate 
subsequent progression to malignancy, as previously reported by Nelson et al 
(2004). It has also been reported that such elevated levels of H2O2 and 
superoxide anion could induce mitogenesis, cell proliferation and malignant 
transformation of several mammalian cell types (D'Souza et al, 1993).  
One of the novels of this study could be the positive correlation 
observed between the number of myoma nodules and plasma level of CRP in 
our leiomyoma patients. This could be an expression of level of 
inflammatory response in the patients. Previous reports show that activated 
macrophages secrete several cytokines (i.e. interleukin-6) capable of 
initiating the production of CRP and other spectrum of acute phase proteins 
by the hepatocytes (Jabbour et al, 2009). The physiological roles of the CRP 
include regulation of immune responses, mediation and inhibition of 
inflammation, acting as transport proteins for products generated during the 
inflammatory process, acting as opsonins, prevention of apoptosis, activation 
of complements, binding of cellular remnants like nuclear fractions 
(Rienhoff, 1990), scavenging free haemoglobin and radicals, repairs and 
remodeling of tissue. Increased level of CRP observed in this study 
corroborates the findings of Hemilä et al (1987) that CRP increased 
significantly in leiomyoma patients. Therefore, elevated CRP in uterine 
leiomyoma patient may suggest possibility of chronic inflammation. It may 
also be a protective immunologic measure, employed by the hepatocytes to 
reduce the risks associated with inflammation (Jabbour et al, 2009).  
The tissue level of cortisol is controlled by 11-beta hydroxysteroid 
dehydrogenase -1 (11-beta HSD-1) that catalyzes the conversion of 
biologically inert cortisone to biologically active cortisol, while 11-beta 
HSD-2 utilizes the cofactor NAD+ to convert cortisol to cortisone. 
Antagonistic effects of cortisol on 17-beta-estradiol in the rat uterus (Rhen et 
al, 2003) indicate that cortisol inhibits leiomyoma growth induction of 
estradiol. The insignificant change observed in the level of cortisol in our 
uterine leiomyoma patients could be due to local regulation of cortisol 
biosynthesis in reproductive tissue, through the oxidative activity of 11-beta 
HSD that catalyzes both oxidative and reductive reactions of glucocorticoids 
(Michael et al, 2003).  
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Conclusion: Elevated levels of CRP and TPP could indicate oxidative stress 
and inflammatory response (respectively) in uterine leiomyoma patients. The 
induced inflammation and oxidative stress may increase with increase in 
number and size of the myoma nodules respectively. Adjuvant antioxidant 
and anti-inflammatory therapies may be needed to avert the consequences of 
oxidative stress and chronic inflammation that could lead to malignant 
transformation of myomas. Higher level of CA125 could be a confirmation 
that uterine leiomyoma is a tumor.  
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